Category: iCarbonX

iCarbonX Pharmaceutical Initiates Phase I Clinical Study of Antimicrobial Peptide Drug Candidate iCAMP016 On May 8, 2026, the initiation meeting for the Phase I clinical study of iCAMP016, an antimicrobial peptide drug candidate developed by iCarbonX Pharmaceutical,…

IVD Reagent Products iCarbonX IntelliCore has developed an in vitro diagnostic product portfolio based on silicon-based peptide chips and PNA chips, covering oncology, autoimmune diseases, allergies, and pathogen detection. The silicon-based chip platform offers high…